Antiretroviral treatment in HIV infection: Early EEG and otoneurological changes and their signification for the disease prognosis;Effet du traitement antiretroviral sur les manifestations electroencephalographiques et otoneurologiques precoces de l'infection a VIH et signification pronostique des perturbations constatees

Neurophysiologie Clinique

Volumn 27, Issue 6, 1997, Pages 508-519

  Burquier, V ^a   Koralnik, I J ^b   Vibert, D ^a   Burkhard, P ^a   Beaumanoir, A ^a   Jallon, P ^a   Mayer, E ^a   Hirschel, B ^a  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^b Beth Israel Deaconess Medical Center   (United Kingdom)

Author keywords

AIDS dementia complex; EEG; Electrophysiology; HIV 1 infection; Otoneurology

Indexed keywords

DIDANOSINE; ZIDOVUDINE; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DEMENTIA; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; ELECTROENCEPHALOGRAM; HOMOSEXUALITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; PROGNOSIS; ELECTROENCEPHALOGRAPHY; FOLLOW UP; HEARING TEST; NEUROLOGIC EXAMINATION; PATHOPHYSIOLOGY; RANDOMIZED CONTROLLED TRIAL; REPRODUCIBILITY;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ANTI-HIV AGENTS; CROSS-OVER STUDIES; DIDANOSINE; DOUBLE-BLIND METHOD; ELECTROENCEPHALOGRAPHY; FOLLOW-UP STUDIES; HEARING TESTS; HIV-1; HUMANS; MALE; NEUROLOGIC EXAMINATION; PROGNOSIS; REPRODUCIBILITY OF RESULTS; ZIDOVUDINE;

EID: 0031301718     PISSN: 09877053     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0987-7053(97)82022-9     Document Type: Article

References (38)

1. Beaumanoir A, Nahory A. L'EEG dans l'infection par le VIH. Neurophysiol Clin 1992;22: 355-68
2. Beaumanoir A, Häusler R, Magistris M, Nahory A, Safran A. Explorations fonctionnelles électrophysiologiques du système nerveux-Précis d'électroneurophysiologie clinique. Med Hyg (Genève) 1985;328-62
3. Beaumanoir A, Burkhard P, Gauthier G, Le Floch-Rohr J, Ochsner F, Waldvogel F. EEG dans 19 cas de sida avec atteinte de l'encéphale. Neurophysiol Clin 1988;18:313-22
4. Birchall MA, Wight RG, French PD, Cockbain Z, Smith S. Auditory function in patients infected with the human immunodeficiency virus. Clin Otolaryngol 1992;17:117-21
5. Bonnardel R. B53, Test d'intelligence non verbale. Issy-les-Moulineaux: Éditions scientifiques et psychologiques, 1977a
6. Bonnardel R, Examen B. Batterie factorielle standard. Issy-les-Moulineaux: Éditions scientifiques et psychologiques, 1977b
7. Brickenkamp R. Test D2. 1966
8. Chiappa K. Evoked potentials in clinical medicine. New York: Raven Press, 1983
9. Darbyshire JH, Aboulker JP. Didanosine for zidovudine-intolerant patients with HIV disease. Lancet (London) 1992;340:1346-7
10. Davis LE, Hjelle BL, Miller VE et al. Early viral brain invasion in iatrogenic human immunodeficiency virus infection. Neurology 1992; 42:1736-9
11. De Gans J, Portegies P. Neurological complications of infection with human immunodeficiency virus type 1. A review of literature and 241 cases. Clin Neurol Neurosurg 1989;91:199-219
12. De la Monte SM, Ho DD, Schooley RT, Hirsch MS, Richardson EP. Subacute encephalomyelitis of AIDS and its relation to HTLV-III infection. Neurology 1987;37:562-9
13. Elovaara I, Saar P, Valle SL, Hokkanen L, Iivanainen M, Lahdevirta J. EEG in early HIV-1 infection is characterized by anterior dysrhythmicity of low maximal amplitude. Clin Electroencephalogr 1991;22:131-40
14. Goodin DS, Aminoff MJ, Chernoff DN, Hollander H. Long latency event-related potentials in patients infected with human immunodeficiency virus. Ann Neurol 1990;27:414-9
15. Gray F, Lescs MC, Keohane C et al. Early brain changes in HIV infection: neuropathological study of 11 HTV seropositive, non-AIDS cases. J Neuropathol Exp Neurol 1992;51:177-85
16. Häusler R, Vibert D, Koralnik IJ, Hirschel B. Neuro-otological manifestations in different stages of HIV infection. Acta Otolaryngology 1991;(suppl) 481:515-21
17. Ho DD, Bredesen DE, Vinters HV, Daar ES. The acquired immunodeficiency syndrome (AIDS) dementia complex (clinical conference). Ann Intern Med 1989;111:400-10
18. Jabbari B, Coats M, Salazar A, Martin A, Scherokman B, Laws WA. Longitudinal study of EEG and evoked potentials in neurologically asymptomatic HIV infected subjects. Electroencephalogr Clin Neurophysiol 1993;3: 145-51
19. Jakobsen J, Smith T, Gaub J, Helweg Larsen S, Trojaborg W. Progressive neurological dysfunction during latent HIV infection. BMJ 1989;299:225-8
20. Janssen RS, Nwanyanwu OC, Selik RM, Stehr Green JK. Epidemiology of human immunodeficiency virus encephalopathy in the United States. Neurology 1992;42:1472-6
21. Koralnik IJ, Beaumanoir A, Häusler R et al. A controlled study of early neurologic abnormalities in men with asymptomatic human immunodeficiency virus infection. N Engl J Med 1990;323:864-70
22. Koralnik IJ, Hirschel B. EEG findings in asymptomatic HIV (letter). Neurology1993; 43:635-6
23. Lang W, Miklossy J, Pizzolato GP, Probst A, Schaffner T, Gessaga E. Neuropathology of the acquired immune deficiency syndrome (AIDS): a report of 135 consecutive autopsy cases from Switzerland. Acta Neuropathologica 1989;77:379-90
24. Malessa R, Agelink M, Brockmeyer N, Hengge U, Baumann M, Weiller C. (1992) Three-year follow-up of brainstem auditory evoked potentials in HIV patients treated and untreated with zidovudine. VIII international conference on AIDS - Amsterdam (abstract)
25. Marshall DW, Brey RL, Cahill WT, Houk RW, Zajac RA, Boswell RN. Spectrum of cerebrospinal fluid findings in various stages of human immunodeficiency virus infection. Arch Neurol 1988;45:954-8
26. McArthur JC, Hoover DR, Bacellar H, Miller EN, Cohen BA, Becker JT et al. Dementia in AIDS patients: incidence and risk factors. Multicenter AIDS cohort study. Neurology 1993;43: 2245-52
27. McLeod G, Hammer SM. Zidovudine: five years later. Ann Intern Med 1992;117:487-501
28. Nuwer MR, Miller EN, Visscher BR, Satz P. Early neurologic abnormalities in HIV infection (letter; comment). N Engl J Med 1991; 324:492-3
29. Nuwer MR, Miller EN, Visscher BR, Niedermeyer E, Packwood JW, Carlson LG et al. Asymptomatic HIV infection does not cause EEG abnormalities: results from the multicenter AIDS cohort study (MACS). Neurology 1992;42:1214-9
30. Olio C, Johnson R Jr, Grafman J. Signs of cognitive change in HIV disease: an event-related brain potential study. Neurology 1991;41:209-15
31. Parisi A, Di Perri G, Strosselli M, Sandrini G, Cairoli S, Minoli L. Instrumental evidence of zidovudine effectiveness in the treatment of HIV-associated subacute encephalitis (letter). AIDS (Philadelphia) 1988;2:482-3
32. Parisi A, Di Perri G, Strosselli M, Nappi G, Minoli L, Rondanelli E. Usefulness of computerized electroencephalography in diagnosing, staging and monitoring AIDS-dementia complex. AIDS (Philadelphia) 1989;3:209-13
33. Price RW, Brew B, Sidtis J, Rosenblum M, Scheck AC, Cleary P. The brain in AIDS: central nervous system HIV-1 infection and AIDS dementia complex. Science 1988;239: 586-92
34. Resnick L, Berger JR, Shapshak P, Tourtellotte WW. Early penetration of the blood-brain-barrier by HIV. Neurology 1988;38:9-14
35. Riedel RR, Helmstaedter C, Bulau P et al. Early signs of cognitive deficits among human immunodeficiency virus-positive hemophiliacs. Acta Psychiatr Scand 1992;85:321-6
36. Rosenhall U, Hakansson C, Lowhagen GB, Hanner P, Jonsson Ehk B. Otoneurological abnormalities in asymptomatic HIV-seropositive patients. Acta Neurol Scand 1989;79:140-5
37. Somma-Mauvais H, Regis H, Gastaut JL, Gastaut JA, Farnarier G. Potentiels évoqués multi-modaux dans l'infection par le virus de l'immunodéficience humaine. Rev Neurol 1990;146:196-204
38. Somma-Mauvais H, Farnarier G. Aspects des potentiels évoqués dans l'infection par le VIH. Neurophysiol Clin 1992;22:369-78